Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

hca healthcare inc. - HCA

HCA

Close Chg Chg %
345.82 0.20 0.06%

Closed Market

346.02

+0.20 (0.06%)

Volume: 1.23M

Last Updated:

Apr 1, 2025, 3:59 PM EDT

Trade Now

Company Overview: hca healthcare inc. - HCA

HCA Key Data

Open

$346.54

 Day Range

342.76 - 347.98

52 Week Range

290.05 - 417.08

 Market Cap

$85.08B

Shares Outstanding

246.20M

 Public Float

174.51M

Beta

1.49

 Rev. Per Employee

N/A

P/E Ratio

15.55

 EPS

$22.26

Yield

77.16%

 Dividend

$0.72

EX-DIVIDEND DATE

Mar 17, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.53M

  

HCA Performance

1 Week
 
 0.99%
 
1 Month
 
 12.81%
 
3 Months
 
 15.13%
 
1 Year
 
 3.60%
 
5 Years
 
 322.28%
 

HCA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 28
Full Ratings ➔

About hca healthcare inc. - HCA

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

HCA At a Glance

HCA Healthcare, Inc.
One Park Plaza
Nashville, Tennessee 37203-6527
Phone 1-615-344-9551 Revenue 70.60B
Industry Hospital/Nursing Management Net Income 5.76B
Sector Health Services 2024 Sales Growth 8.674%
Fiscal Year-end 12 / 2025 Employees 316,000
View SEC Filings

HCA Valuation

P/E Current 15.552
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.643
Price to Sales Ratio 1.113
Price to Book Ratio N/A
Price to Cash Flow Ratio 7.474
Enterprise Value to EBITDA 9.009
Enterprise Value to Sales 1.768
Total Debt to Enterprise Value 0.362

HCA Efficiency

Revenue/Employee 223,427.215
Income Per Employee 18,227.848
Receivables Turnover 6.54
Total Asset Turnover 1.22

HCA Liquidity

Current Ratio 1.082
Quick Ratio 0.967
Cash Ratio 0.133

HCA Profitability

Gross Margin 14.938
Operating Margin 14.938
Pretax Margin 12.072
Net Margin 8.158
Return on Assets 9.955
Return on Equity N/A
Return on Total Capital 13.477
Return on Invested Capital 15.361

HCA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 105.847
Total Debt to Total Assets 76.012
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 94.052
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hca Healthcare Inc. - HCA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
58.75B 60.23B 64.97B 70.60B
Sales Growth
+14.01% +2.52% +7.86% +8.67%
Cost of Goods Sold (COGS) incl D&A
49.07B 51.18B 55.34B 60.06B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.85B 2.97B 3.08B 3.31B
Depreciation
2.83B 2.94B 3.05B 3.29B
Amortization of Intangibles
27.00M 28.00M 25.00M 18.00M
COGS Growth
+10.85% +4.29% +8.13% +8.52%
Gross Income
9.68B 9.05B 9.63B 10.55B
Gross Income Growth
+33.27% -6.46% +6.34% +9.56%
Gross Profit Margin
+16.47% +15.03% +14.82% +14.94%
2021 2022 2023 2024 5-year trend
SG&A Expense
- - - -
-
Research & Development
- - - -
-
Other SG&A
- - - -
-
SGA Growth
- - - -
-
Other Operating Expense
- - - -
-
Unusual Expense
- - 12.00M 78.00M
-
EBIT after Unusual Expense
9.67B 8.97B 9.63B 10.55B
Non Operating Income/Expense
1.70B 1.34B 17.00M 37.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
113.00M 45.00M 22.00M 23.00M
Interest Expense
1.53B 1.74B 1.94B 2.06B
Interest Expense Growth
-1.99% +13.73% +11.44% +6.35%
Gross Interest Expense
1.53B 1.74B 1.94B 2.06B
Interest Capitalized
- - - -
-
Pretax Income
9.83B 8.58B 7.71B 8.52B
Pretax Income Growth
+81.09% -12.74% -10.19% +10.60%
Pretax Margin
+16.74% +14.24% +11.86% +12.07%
Income Tax
2.11B 1.75B 1.61B 1.87B
Income Tax - Current - Domestic
2.08B 1.43B 1.33B 1.41B
Income Tax - Current - Foreign
15.00M 18.00M 3.00M 20.00M
Income Tax - Deferred - Domestic
6.00M 288.00M 262.00M 425.00M
Income Tax - Deferred - Foreign
11.00M 12.00M 19.00M 7.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
113.00M 45.00M 22.00M 23.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
7.72B 6.83B 6.09B 6.66B
Minority Interest Expense
765.00M 1.19B 849.00M 897.00M
Net Income
6.96B 5.64B 5.24B 5.76B
Net Income Growth
+85.30% -18.88% -7.11% +9.88%
Net Margin Growth
+11.84% +9.37% +8.07% +8.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
6.96B 5.64B 5.24B 5.76B
Preferred Dividends
- - - -
-
Net Income Available to Common
6.96B 5.64B 5.24B 5.76B
EPS (Basic)
21.5146 19.4353 19.2435 22.2735
EPS (Basic) Growth
+93.87% -9.66% -0.99% +15.75%
Basic Shares Outstanding
323.31M 290.35M 272.40M 258.60M
EPS (Diluted)
21.1588 19.1505 18.9644 22.001
EPS (Diluted) Growth
+93.67% -9.49% -0.97% +16.01%
Diluted Shares Outstanding
328.75M 294.67M 276.41M 261.81M
EBITDA
12.53B 12.02B 12.70B 13.86B
EBITDA Growth
+25.52% -4.06% +5.67% +9.09%
EBITDA Margin
+21.33% +19.96% +19.55% +19.63%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 379.045
Number of Ratings 28 Current Quarters Estimate 6.289
FY Report Date 06 / 2025 Current Year's Estimate 24.869
Last Quarter’s Earnings 5.77 Median PE on CY Estimate N/A
Year Ago Earnings 21.96 Next Fiscal Year Estimate 27.959
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 18 23 21
Mean Estimate 6.29 5.60 24.87 27.96
High Estimates 7.04 5.92 25.43 29.37
Low Estimate 5.77 5.20 23.41 25.26
Coefficient of Variance 4.52 3.18 1.64 3.23

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 15 15 15
OVERWEIGHT 4 4 4
HOLD 8 8 8
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Hca Healthcare Inc. - HCA

Date Name Shares Transaction Value
Sep 13, 2024 Michael S. Cuffe EVP and Chief Clinical Officer 51,758 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $145.24 per share 7,517,331.92
Sep 13, 2024 Michael S. Cuffe EVP and Chief Clinical Officer 38,036 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $386.43 per share 14,698,251.48
Sep 13, 2024 Michael S. Cuffe EVP and Chief Clinical Officer 29,678 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $385.42 per share 11,438,494.76
Sep 13, 2024 Michael S. Cuffe EVP and Chief Clinical Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 29, 2024 Thomas Fearn Frist Director 13,497 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 29, 2024 William Robert Frist Director 11,905 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer 9,454 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $326.3 per share 3,084,840.20
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer 11,318 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $322.86 per share 3,654,129.48
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer 12,494 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $101.16 per share 1,263,893.04
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer 12,045 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 21, 2024 Kathleen M. Whalen SVP & Chief Ethics Officer 14,179 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $133.53 per share 1,893,321.87
May 14, 2024 Jeff E. Cohen SVP-Government Relations 5,185 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $313 per share 1,622,905.00
May 14, 2024 Erol R. Akdamar Group President N/A Bona fide gift 0.00
May 14, 2024 Erol R. Akdamar Group President 60,497 Bona fide gift 0.00
May 9, 2024 Michael S. Cuffe EVP and Chief Clinical Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 7, 2024 Kathryn A Torres SVP-Payer Contracting & Align. 21,475 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $312 per share 6,700,200.00
May 7, 2024 Kathryn A Torres SVP-Payer Contracting & Align. 22,365 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $312 per share 6,977,880.00
May 2, 2024 Mike A. Marks EVP and CFO 2,237 Bona fide gift 0.00
May 2, 2024 Michael Mcalevey EVP - Chief Legal & Admin Off 2,274 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Hca Healthcare Inc. in the News